IL18 and cystic fibrosis: The persistent UPRmt activation also increased the inflammatory-sensitivity of CF cells to pathogen, as shown by higher levels of NLRP3 inflammasome-dependent IL-1β and IL-18 released during infection (Rimessi et al., 2020b).